Stockwinners Market Radar for February 03, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

18:51 EST Takeda Pharmaceutical: FDA approves sBLA for expanded use of TAKHZYRO - Takeda announced that the U.S. FDA has approved the supplemental Biologics License Application for the expanded use of TAKHZYRO for prophylaxis to prevent attacks of hereditary angioedema in pediatric patients 2 to less than12 years of age. Prior to this approval, the only approved routine prophylaxis treatment options for children 6 to less than12 years of age required dosing every three to four days, and children with HAE 2 to less than 6 years of age had no approved prophylaxis treatment, making TAKHZYRO the first prophylaxis treatment for this age group. The recommended dose is 150 mg/1 mL solution in a single-dose prefilled syringe every four weeks in patients 2 to less than 6 years of age and every two weeks in patients 6 to less than 12 years of age.

18:16 EST Atento announces successful capital raise - Atento confirms that it has secured its previously announced financing program. The additional capital raised will further strengthen Atento's balance sheet and liquidity position as management focuses on transforming the business. The fourth quarter has continued the positive trend by generating strong EBITDA margin growth, delivering the cash balance to close at $84M on December 31, 2022.

17:46 EST ArrowMark Financial Corp. reports estimated NAV $20.79 as of December 31 - This NAV reflects the regular fourth quarter dividend of 39c per share plus the special dividend of 10c per share.

17:02 EST Forest Road Acquisition Corp. II, HyperloopTT terminate merger agreement - Hyperloop Transportation Technologies and Forest Road Acquisition Corp. II have mutually agreed to terminate their previously announced business combination agreement. Considering the significant time to close the business combination, coupled with prevailing market conditions, both parties decided that terminating the agreement is in the best interest of their respective shareholders and employees.

16:49 EST KVH Industries enters support agreement with Black Diamond Capital - KVH Industries announced that it has entered into a support agreement with Black Diamond Capital Management, L.L.C. and certain of its affiliates. Pursuant to the Agreement, the company has committed to nominate and support Black Diamond Managing Principal Stephen Deckoff as an independent Class III director at the company's 2023 Annual Meeting of Stockholders, subject to certain conditions. Deckoff will begin serving as a non-voting observer of the company's Board of Directors. Additionally, the company has granted Black Diamond a waiver under the company's stockholder rights plan allowing Black Diamond to acquire up to 25% of the company's outstanding common stock. The company will accept the resignation of one of its incumbent directors, which resignation will become effective at the 2023 Annual Meeting. Following the election of Deckoff at the 2023 Annual Meeting, the KVH Board will continue to have seven directors.

16:37 EST RH sees FY22 revenue growth at low end of prior range of (3.5%)-(4.5%) - Sees FY22 adjusted operating margin toward the higher end of the prior range of 21.5%-22.0%. Guidance provided in regulatory filing.

16:15 EST Surmodics initiates organizational changes, cuts workforce by about 13% - According to a regulatory filing, on January 30, 2023, Surmodics initiated certain organizational changes designed to align its human resources with its business needs and to reduce its use of cash. The organizational changes were prompted by the decision of the U.S. Food and Drug administration to request additional information and data related to the premarket approval application for the company's SurVeil drug-coated balloon, which led the company to reassess the timing of a potential related milestone payment that would be due following approval and subsequent commercial revenue related to its distribution of the product. The organizational changes will result in a reduction in the company's workforce by approximately 13%. In connection with the workforce reduction, the company expects to record total restructuring charges of approximately $1M to $1.2M in the second quarter of fiscal 2023. These charges represent cash expenditures for severance, benefits continuation, outplacement, and other costs. The workforce reduction is expected to be completed within the company's second fiscal quarter.

16:06 EST Brixmor chair John Schreiber to retire, Crosland named next chair - Brixmor Property Group announced that John G. Schreiber, the chair of the company's board of directors, will retire from the Board at the end of his current term, which will conclude as of the adjournment of the 2023 Annual Meeting of the company's Stockholders. Schreiber has served as chair of the Board since the company's initial public offering in 2013. Sheryl M. Crosland, a current independent director, will replace Schreiber as chair of the Board effective as of his retirement. "John's vision, wisdom and strategic leadership have been immensely valuable to the Board and management and have been a critical part of our success," commented James Taylor, CEO and President. "We are grateful for John's many contributions, for his unerring judgment, for his incisive wit, and for his service and dedication to our Company and our stockholders. We are a better company for having had the benefit of working with John. We thank John and wish him the very best. We are excited to have Sheryl assume the role of Chair and look forward to benefitting from her capable leadership and deep industry experience."

14:47 EST Charter discloses legal settlements reached in January in annual filing - In the company's annual report on form 10-K with the SEC, filed on January 27, Charter disclosed: "In August 2015, a purported stockholder of Charter, Matthew Sciabacucchi, filed a lawsuit in the Delaware Court of Chancery, on behalf of a putative class of Charter stockholders, challenging the transactions involving Charter, TWC, A/N, and Liberty Broadband announced by Charter on May 26, 2015. The lawsuit, which named as defendants Charter and its board of directors, alleged that the transactions resulted from breaches of fiduciary duty by Charter's directors and that Liberty Broadband improperly benefited from the challenged transactions at the expense of other Charter stockholders. On January 12, 2023, the parties reached a tentative agreement to settle the lawsuit. The settlement is subject to preliminary and final approval by the court and will result in a net payment to Charter as a result of the settlement of the derivative claims by the plaintiffs. The Company cannot provide assurance that this tentative settlement will be finalized and approved by the court. Pending finalization of the settlement and in the event the settlement is not finalized and approved by the court, the Company will continue to vigorously defend this lawsuit. Although Charter is unable to predict the outcome of this lawsuit, it does not expect the outcome will have a material effect on its operations, financial condition or cash flows... In March 2020, Charter Communications, LLC, an indirect subsidiary of the Company, was named as a defendant in a lawsuit filed in Dallas, Texas related to the fatal stabbing of an individual in her home by an off duty CC, LLC technician: William Goff, as Personal Representative of Betty Jo McClain Thomas, deceased, et al. v. Roy James Holden, Jr. and Charter Communications, LLC, Case No. CC-20-01579-E, pending in County Court at Law No. 5 for Dallas County, Texas. The complaint alleged that CC, LLC was responsible for Mrs. Thomas' death. Following a two phase trial, the jury returned a verdict finding CC, LLC ninety percent at fault for Mrs. Thomas' death, and awarded compensatory damages of $375 million to plaintiffs and then awarded $7.0 billion in punitive damages to plaintiffs on July 26, 2022. On October 7, 2022, plaintiffs filed a motion for a judgment that proposed a reduced total award of $1.1 billion. The trial judge signed the judgment, and CC, LLC posted a $25 million bond to stay the judgment pending appeals. On January 11, 2023, and after issuing a series of decreasing settlement demands over several months, the plaintiffs issued a new, lower settlement demand to CC, LLC and its insurers, and then on January 18, 2023, plaintiffs also filed a notice of remittitur with the court to further reduce the judgment to $262 million, comprised of $87 million in actual damages, and $175 million in punitive damages. On January 24, 2023 and upon the insistence and demand of its insurers, CC, LLC reached a tentative settlement of this lawsuit at an amount substantially less than the reduced judgment and within CC, LLC's insurance coverage. In the event the settlement is not ultimately finalized, CC, LLC will continue to vigorously defend this lawsuit including pursuing all available appeals."

13:24 EST Commerce Bancshares increases quarterly dividend to 27c per share from 25.2c - Commerce Bancshares announced that its Board of Directors declared a quarterly dividend of 27c per share on the company's common stock, which compares to the prior dividend of 25.2c as adjusted for the 5% stock dividend that was paid on December 19, 2022. This represents an increase in the quarterly dividend per share of 7% and marks the 55th consecutive year that the company has increased its regular cash dividend per share. The dividend is payable on March 27, 2023 to stockholders of record at the close of business on March 7, 2023.

13:01 EST Baker Hughes reports U.S. rig count down 12 to 759 rigs

12:51 EST SINTX Technologies Inc trading halted, volatility trading pause

12:11 EST Google, Anthropic partner to co-develop AI computing systems - Google Cloud announced a new partnership with Anthropic, an AI startup focused on safety and research. Anthropic has selected Google Cloud as its preferred cloud provider, giving it the compute power necessary to build reliable and trustworthy AI systems. Additionally, Google Cloud intends to build large-scale, next-generation TPU and GPU clusters that Anthropic plans to use to train and deploy its cutting-edge AI systems. "We're thrilled to be able to partner with Google Cloud on training and deploying useful AI systems," said Anthropic CEO Dario Amodei. "We've been impressed with Google Cloud's open and flexible infrastructure. We are excited to partner with Google to scale-up our systems in the coming months." "At Google, we believe it is imperative to pursue AI boldly and responsibly," said James Manyika, SVP of Technology and Society, Google. "We are committed to developing and delivering useful and beneficial applications, applying responsible principles grounded in human values and safety, and evolving our approaches as we learn from research, experience, users, and the wider community. Our partnership with Anthropic is aligned with that philosophy." Reference Link

12:00 EST Bill.com falls -25.8% - Bill.com is down -25.8%, or -$33.22 to $95.69.

12:00 EST Nordstrom rises 18.4% - Nordstrom is up 18.4%, or $3.89 to $25.03.

12:00 EST BigBear.ai rises 36.9% - BigBear.ai is up 36.9%, or $1.33 to $4.93.

11:54 EST Motorsport Games Inc trading halted, volatility trading pause

11:35 EST Kalera PLC trading resumes

11:25 EST Kalera PLC trading halted, volatility trading pause

10:55 EST Viveon Health Acquisition terminates merger agreement with Suneva Medical - Viveon Health Acquisition Corp. announced that it has unilaterally terminated its previously announced agreement and plan of merger with Suneva Medical, Inc. As a result, Viveon will seek an alternative business combination.

10:40 EST 1Life dips after WSJ says FTC considering antitrust suit against Amazon - Shares of 1Life Healthcare (ONEM) are down 41c or about 3%, to $15.21 in morning trading after The Wall Street Journal's Dana Mattioli and Brent Kendall reported, citing sources, that The Federal Trade Commission is considering challenges to an array of practices by Amazon (AMZN) that it considers anticompetitive. Which aspects of Amazon's business the FTC would target in a potential Amazon lawsuit couldn't be learned, the report said. Amazon has entered into an agreement to acquire 1Life, which operates a membership-based primary care platform under the One Medical brand.

10:34 EST PONOU Stock trading resumes

10:24 EST PONOU Stock trading halted, volatility trading pause

10:00 EST GrafTech falls -14.3% - GrafTech is down -14.3%, or -94c to $5.65.

10:00 EST Kemper rises 9.0% - Kemper is up 9.0%, or $5.09 to $61.70.

10:00 EST Nordstrom rises 26.1% - Nordstrom is up 26.1%, or $5.52 to $26.66.

09:47 EST Beazer Homes falls -13.3% - Beazer Homes is down -13.3%, or -$2.30 to $15.02.

09:47 EST Direxion Daily Junior Gold Miners Index Bear 3x Shares rises 7.3% - Direxion Daily Junior Gold Miners Index Bear 3x Shares is up 7.3%, or 48c to $7.08.

09:47 EST Nordstrom rises 26.2% - Nordstrom is up 26.2%, or $5.53 to $26.67.

09:37 EST ReShape Lifesciences Inc trading resumes

09:32 EST ReShape Lifesciences Inc trading halted, volatility trading pause

09:27 EST Helbiz receives extension to regain compliance with Nasdaq - Helbiz announced that it received notice from the Nasdaq Listing Qualifications Panel of Nasdaq that it has granted the company an extension to regain compliance with the continued listing requirements for Nasdaq.

09:19 EST Entravision increases quarterly cash dividend to 5c per share - Entravision announced that its board of directors approved a quarterly cash dividend to shareholders of 5c per share of the company's Class A, Class B and Class U common stock. This reflects a doubling of its previous quarterly dividend of 2.5c per share in 2022 and returns the dividend to its pre-pandemic level. The company anticipates an aggregate payout amount of approximately $4.4M. This quarterly dividend is payable on March 31 to shareholders of record as of the close of business on March 16 and the common stock will trade ex-dividend on March 15. The company currently anticipates that future cash dividends will be paid on a quarterly basis; however, any decision to pay future cash dividends will be subject to approval by the board.

09:18 EST Crown Electrokinetics closes line of credit for up to $100M - Crown Electrokinetics announced that it has closed a line of credit for up to $100M In early January, Crown announced that it had entered into an asset purchase agreement with Amerigen 7. Crown did this for two primary reasons; to market and sell distributed antennas systems to its targeted customer base and to generate revenue and cash flow from the construction of the fiber optic network for Charter Communications. The business has been rebranded and renamed as Crown Fiber Optics. The Company believes the acquisition could add revenue of approximately $30M and EBITDA of $10M in 2023.

09:02 EST Heart Test announces further internationalization of patent portfolio - Heart Test Laboratories, d/b/a HeartSciences, announced it has been granted Korean Patent No. 10-2490960 from the Korean Intellectual Property Office, KIPO. To date HeartSciences has been granted nine US patents and 30 international patents for a total of 39 granted patents. The Company has nine additional patents pending across the US and international markets. Andrew Simpson, Chief Executive Officer of HeartSciences, commented, "Millions of ECG's are performed worldwide every week and the ECG is by far the most ubiquitous cardiac test. The addition of cardiac dysfunction detection to the ECG is expected to provide significant benefit to healthcare providers and health systems around the world. Cardiovascular disease accounts for 17.9 million deaths, an estimated 32% of all deaths worldwide. The MyoVista(R) could play a significant role in heart health screening worldwide." Simpson continued, "Given the scale of the global market, protection of our intellectual property and patents in major markets is core to the Company as it provides intrinsic value to HeartSciences and would be expected to be a source of major competitive advantage as we move toward commercialization. This latest patent further expands our international coverage and is the latest addition to our extensive patent portfolio."

08:47 EST Personalis, Moderna announce new agreement to leverage NeXT Platform - Personalis (PSNL) and Moderna (MRNA) announced the companies have signed a new agreement to continue using the Personalis NeXT Platform as part of upcoming clinical studies evaluating mRNA-4157/V940, an investigational personalized cancer vaccine, jointly developed by Moderna and Merck, known as MSD outside of the United States and Canada. The platform, which was also utilized in the vaccine candidate's Phase 2b clinical study, will be used to sequence genomic information from a patient's tumor sample to identify the unique genetic mutations that are most likely to generate a tailored antitumor response.

08:46 EST Park Hotels & Resorts announces $118.25M sale of 508-room Hilton Miami Airport - Park Hotels & Resorts announced that it has closed on the sale of the 508-room Hilton Miami Airport located in Miami, Florida for $118.25M, or $233,000 per key. When adjusted for Park's anticipated capital expenditures, the sale price represents a 6.2% capitalization rate on 2019 net operating income, or 14.0x 2019 EBITDA. Proceeds from the sale will be used to pay off the outstanding $50M revolver balance and for general corporate purposes.

08:37 EST Presidio Property Trust sold 31 model homes in 2022 - The company said, "During 2022, we sold 31 model homes for approximately $17.5 million, recording a gain on sale of approximately $5.4 million. When purchased these model homes were newly constructed single-family homes that were leased back to the homebuilders on a triple-net basis. The 31 model homes were held for an average of 3.6 years, with an average purchase price of approximately $391,000 per home. The average sales price for the model homes sold in 2022 was approximately $565,000 per home."

08:35 EST Predictive Oncology appoints Pamela Bush as CBO - Predictive Oncology announces the appointment of Pamela Bush, Ph.D., MBA, as Chief Business Officer. Dr. Bush will lead all business development, partnering and growth strategies for Predictive Oncology. As a key member of the executive team, Dr. Bush will spearhead the company's strategic, operational and financial planning initiatives for both existing customers and emerging new markets. She will work closely with the company's senior management in leveraging and expanding its portfolio of proprietary solutions to advance drug discovery and enable oncology drug development for the company's biopharma partners.Bush previously served as Senior Vice President of Strategic Sales and Business Development at Predictive Oncology.

08:34 EST Par Pacific sees Q4 adjusted EBITDA $160M-$180M - Sees net income $60M-$90M, adjusted net income $117M-$138.5M.

08:33 EST NetSol Technologies extends its partnership with Amazon Web Services - NETSOL Technologies (NTWK) announces that it has become an API Gateway Delivery Partner with Amazon (AMZN) Web Services. With this extended APN partnership, NETSOL will have access to AWS API Gateway, a fully managed service that makes it easy for developers to create, publish, maintain, monitor, and secure APIs at any scale. This partnership is expected to position NETSOL to expand its capabilities and better serve its clients in a variety of industries. "We are excited to extend our partnership level with the AWS Partner Network (APN) and become an API Gateway Delivery Partner," said Peter Minshall, Executive Vice President, NETSOL Technologies Americas. "This partnership will allow us to provide even more robust and reliable solutions for our clients by utilizing the power and scale of the AWS platform."

08:30 EST Dassault Aviation launches EICACS project - Dassault Aviation hosted at its Saint-Cloud headquarters, the kick-off meeting of the EICACS project with its European industrial and research partners. The grant contract, awarded by the European Commission on 19 December 2022, designates Dassault Aviation, recognized for its ability to manage complex cooperative programmes, as the coordinator of this study project, which brings together 37 industrial partners and research organizations from 11 European Union countries. Supported by the European Union to the tune of 75 MEUR within the framework of the 2021 programme of the European Defence Fund, this project aims to define, within a European framework, the future interoperability standards for collaborative air combat. It will strengthen the ability of European air forces to fulfill their missions ever more effectively and to act in coalitions involving both manned and unmanned systems, future air combat systems and existing platforms, as well as their upgrades.

08:22 EST Tenax Therapeutics announces pricing of approximately $15.6M public offering - Tenax Therapeutics announced the pricing of a public offering of 8,666,666 shares of its common stock and warrants to purchase up to 17,333,332 shares of its common stock at a purchase price of $1.80 per share and associated Public Warrant. The Public Warrants will have an exercise price of $2.25 per share, are immediately exercisable, and will expire five years after their initial exercise date. The offering is expected to close on or about February 7, 2023, subject to customary closing conditions. Roth Capital Partners is acting as our exclusive placement agent in the offering. Gross proceeds, before deducting placement agent fees and commissions and offering expenses are expected to be approximately $15.6 million. The Company intends to use the net proceeds from the offering to progress the clinical development of imatinib for the treatment of PAH and levosimendan for the treatment of PH-HFpEF, toward regulatory approval for the treatment of these and potentially other indications and, depending on patents pending that the Company expects the USPTO to make throughout 2023 and other factors determining near-term prioritization, channel the net proceeds towards these ends as well as for working capital, capital expenditures, continued product development, and other general corporate purposes.

08:19 EST Arena Group announces strategic development partnerships with two AI firms - Arena Group announced strategic development partnerships with two Artificial Intelligence, or AI, firms - Jasper and Nota - to speed and broaden its AI-assisted efforts in content workflows, video creation, newsletters, sponsored content, and marketing campaigns. The partnerships will unlock new tools for the editorial teams at 250 brands operating on the company's platform, including Sports Illustrated, TheStreet, Parade, and Men's Journal. The company's strategic alignment with Nota initially focuses on AI-assisted video content creation and using AI-enabled tools to streamline workflows. Nota's assistive AI tools provide advanced production infrastructure and increase video content revenue for digital publishers.

08:16 EST Ensysce Biosciences announces $3M registered direct offering - Ensysce Biosciences entered into a definitive agreement for the purchase and sale of 3,571,431 shares of the Company's common stock at a purchase price of $0.84 per share of common stock in a registered direct offering priced at-the-marked under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue warrants to purchase up to 3,571,431 shares of common stock. The warrants have an exercise price of $0.715 per share, are exercisable immediately following issuance and will have a term of five and one-half years from the issuance date. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The closing of the offering is expected to occur on or about February 6, 2023, subject to the satisfaction of customary closing conditions. The gross proceeds to the Company from this offering are expected to be approximately $3 million, before deducting the placement agent's fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from this offering for general corporate purposes, which may include funding capital expenditures and working capital and repaying indebtedness.

08:13 EST A-Mark to purchase minority interest in Atkinsons Bullion & Coins for $2.75M - A-Mark Precious Metals entered into a definitive agreement to purchase a 25% ownership interest in a United Kingdom-based company which owns and operates through a wholly owned subsidiary, Atkinsons Bullions & Coins for cash consideration of $2.75M. Founded in 1990, Atkinsons is a leading United Kingdom-based online retailer of precious metals, bullion and coins. Atkinsons reported revenue of over $130M in calendar 2022. In connection with the agreement, A-Mark and Atkinsons will enter into a three-year supplier agreement which includes a renewal provision. A-Mark will also be granted an option, exercisable no sooner than 24 months after the closing, to purchase an additional 24.5% ownership interest in Atkinsons which, if exercised, would increase A-Mark's ownership interest to 49.5%. The proposed transaction is expected to close in March 2023, subject to customary closing conditions.

08:10 EST Moog increases quarterly dividend 4% to 27c per share - The board of directors of Moog declared a quarterly dividend of 27c per share on the company's issued and outstanding shares of Class A common stock and Class B common stock. The dividend will be paid on March 6 to all shareholders of record as of the close of business on February 17. The 27c per share dividend represents a 4% increase over the previous dividend. The dividend represents a use of cash of approximately $9M. Future declarations of quarterly dividends are subject to the determination and discretion of Moog's board of directors.

08:07 EST Twin Disc says reducing inventory remains key priority during 2H23 - Jeffrey Knutson, Vice President - Finance, CFO, Treasurer and Secretary stated, "We continue to pursue strategies that strengthen our balance sheet and improve our fixed cost structure. The progress we have made during fiscal 2023 is encouraging as we successfully monetize several of our under-utilized assets including our facility in Belgium during the fiscal 2023 second quarter. These actions, combined with positive operating cash flow during the fiscal 2023 second quarter, continued to strengthen our balance sheet and at December 30, 2022, our net debt improved by 23.4% from June 30, 2022. Unfortunately, challenging supply chain and shipping conditions continued to impact inventory levels during the second quarter, and reducing inventory remains a key priority during the second half of fiscal 2023. As our growing backlog converts to sales, we believe we will generate higher levels of positive operating cash flow throughout the remainder of fiscal 2023, further strengthening our balance sheet."

08:02 EST Greenland Technologies regains compliance with Nasdaq listing rules - Greenland Technologies Holding previously announced that it had received a letter on January 4 from the Staff of The Nasdaq Stock Market notifying the Company that it was not in compliance with the annual meeting requirement set forth in Nasdaq Listing Rule 5620 for continued listing on Nasdaq. The Company announced that on February 1 Nasdaq informed the Company that it is now back in compliance with Nasdaq Listing Rule 5620 following its Annual General Meeting held on January 31, 2023 and this matter is now closed.

07:51 EST Avant Brands completes acquisition of Flowr Okanagan - Avant Brands (AVTBF) announced that Avant Brands K1, an entity of which Avant owns 50% of the issued and outstanding shares, closed its previously announced acquisition of all of the issued and outstanding shares in the capital of The Flowr Group, a subsidiary of The Flowr Corporation (FLWPF) on February 1, 2023 pursuant to an amended and restated purchase agreement among the Purchaser, Flowr Okanagan and Flowr Canada Holdings ULC dated December 1, 2022, as amended. As previously announced, the Flowr Okanagan facility will increase Avant's overall square footage of cultivation facilities to approximately 185,000 square feet and is expected to increase Avant's annual production capacity by approximately 60%. It is anticipated that Avant will be one of the largest producers in Canada of indoor grown, ultra-premium cannabis. The aggregate purchase price for the Purchased Shares was equal to $5,115,000, consisting of $3,850,000 payable in cash and satisfied in the manner described below; and 7,402,186 common shares in the capital of Avant with a value of $1,265,000 based on the deemed price of $0.1708955 per Avant Share plus the amount of the Closing DIP Loan; and the value of the Assumed Liabilities, subject to certain adjustments. The Purchase Price was satisfied through: a credit bid of all amounts owing to the Purchaser under the DIP Term Sheet including any accrued and unpaid interest, expenses, fees and other amounts, delivery of the Avant Share Consideration, an amount in cash equal to the Purchase Price less the Credit Bid and the Avant Share Consideration, and the assumption of certain liabilities, as set out in the Purchase Agreement. The Company previously announced that the Purchaser had executed a term sheet with Flowr and its subsidiaries, Flowr Okanagan, Flowr ULC and Terrace Global, pursuant to which the Purchaser advanced a debtor-in-possession loan in connection with the Flowr Group's filing for protection from the Court under the CCAA. On January 31, 2023, the DIP Term Sheet was amended, and the principal amount of the DIP Loan was increased by $500,000 to an aggregate of $2,500,000.

07:48 EST IES Holdings 'optimistic' about long-term fundamentals in 'key markets' - CEO Jeff Gendell continued, "While we were encouraged by strong demand through the first quarter of fiscal 2023, we continue to monitor the impact of changing economic conditions on demand for our services. In particular, we expect elevated interest rates and decreased housing affordability to impact demand in the single-family housing market in the near term. However, we remain optimistic about the long-term fundamentals in our key markets, and believe we are well-positioned to expand our service offerings and pursue market share growth."

07:42 EST Field Trip Health announces posting on the OTC Market - Field Trip Health & Wellness has received approval from the Financial Regulatory Authority for its shares to commence trading on the OTCQB Market in the United States under the symbol "FTHWF" effective February 2, 2023. Field Trip will continue to trade on the TSX Venture Exchange under its existing symbol "FTHW". The Company also announced that as a result, in part, of the announcement by the US government of its intention to end the Public Health Emergency related to the COVID-19 Pandemic, it is re-evaluating its Freedom by Field Trip program. The Freedom by Field Trip program relies on an exception to the Ryan Haight Act that permitted prescribing of controlled substances such as ketamine by telemedicine during the PHE. With the end of the PHE occurring in the first half of 2023, the Company is evaluating its strategy around the Freedom by Field Trip program and, as a result, has stopped enrolling new clients in the program.

07:39 EST Oragenics regains compliance with NYSE - Oragenics announced that the company has received formal notice from the NYSE American stating that the company has regained compliance with the NYSE American's continued listing standards.

07:37 EST Northland Power continues to advance pipeline of up to 15 GW longer-term - Northland remains in a strong position to achieve substantial growth in Adjusted EBITDA by 2027, with over 3.5 GW of projects in construction and/or scheduled for financial close and commencement of construction within the next two years. Once these projects are complete, Northland's total gross capacity will nearly double to more than 6.5 GW by 2027. Longer-term, the Company continues to advance a pipeline of up to 15 GW encompassing its identified projects and additional opportunities to support the sustained growth of the Company.

07:35 EST Cboe Global Markets sees FY23 CapEx $60M-$66M - Cboe provided guidance for the FY23: Sees FY23 organic total net revenue growth 7%-9%, above medium-term organic total net revenue guidance expectations of 5%-7%; revenue from acquisitions held less than a year is expected to contribute total net revenue growth of 0.5% points in 2023; organic net revenue from Data and Access Solutions is expected to increase by approximately 7%-10% in 2023, in line with medium-term guidance expectations; adjusted operating expenses in 2023 are expected to be $769M-$779M, from a base of $652M in 2022. The guidance excludes the expected amortization of acquired intangible assets of $112M; the company plans to reflect the exclusion of this amount in its non-GAAP reconciliation. Depreciation and amortization expense for 2023, which is included in adjusted operating expenses above, is expected to be in the range of $48M-$52M, excluding the expected amortization of acquired intangible assets. Other income net, is expected to contribute a $27M-$33M benefit in 2023 given expected performance of minority investments. The effective tax rate on adjusted earnings for the FY23 is expected to be in the range of 28.5%-30.5%. Significant changes in trading volume, expenses, tax laws or rates and other items could materially impact this expectation. Capital expenditures for 2023 are expected to be $60M-$66M.

07:33 EST Gracell: FDA clears IND application for Phase 1b/2 FasTCAR-T GC012F trial - Gracell Biotechnologies announced that the U.S. FDA has cleared Gracell's Investigational New Drug application and the company can proceed to initiate a Phase 1b/2 clinical trial in the U.S. of GC012F, an autologous CAR-T therapeutic candidate, for the treatment of relapsed/refractory multiple myeloma. The company plans to initiate Phase 1b/2 clinical trial in the U.S. in second quarter of 2023.

07:31 EST Invivyd announces CSO Walker to leave the company - Invivyd announced that Laura Walker, Ph.D., the company's chief scientific officer, CSO, and co-founder, decided to leave the company to pursue other opportunities. The management team has initiated a search process to identify her replacement. Until a permanent successor is named, Invivyd team member Lukas Dillinger, Ph.D., has been appointed as interim Head of Discovery and Pre-Clinical.

07:19 EST Farmland Partners purchases 291 acres of farmland in Illinois for $2.16M - Farmland Partners announced that it purchased 291 acres of farmland in Schuyler County, Illinois, for $2.16M. FPI won the property during an auction held November 29. The newly acquired property is leased to the same tenant who rents FPI's nearby farm. The farmland is expected to generate good rental income for the company in addition to asset appreciation. Agricultural land in Illinois has averaged 5.7% in annual appreciation since 1970, according to the most recent data from the U.S. Department of Agriculture.

07:07 EST Immunovant expects cash to fund operations into 2H25 - As of December 31, 2022, Immunovant's cash and cash equivalents totaled $432.6 million, which is expected to fund operations into the second half of calendar year 2025.

07:05 EST Osino receives multiple project finance offers for Twin Hills Gold project - Osino Resources announces that it has it has received eight project finance offers from credible institutions for the construction financing of its wholly owned Twin Hills Gold Project in Namibia. The receipt of indicative term sheets is an important milestone in the overall financing process and underlines the quality of Namibia as a premier lending jurisdiction and more specifically the financeability of Twin Hills. Heye Daun, Osino's co-founder, President & CEO commented: "We are very pleased with the competitiveness of the process and resulting quality of project financing offers received from 8 reputable institutions with impressive track records of successful project financing. Choosing the appropriate financing partners is an important next step for Osino. We look forward to the appointment of our preferred debt financing provider and finalizing terms in the coming months as we continue to advance the development of Twin Hills."

07:04 EST Dorman Products releases fourth edition of award-winning OE Fix Guide - Dorman Products is announcing the release of OE FIX Guide Vol. 4, its award-winning publication highlighting its most innovative automotive repair solutions designed to help professionals make faster, longer-lasting repairs. Dorman OE FIX parts are "designed to be better-than-OEM replacements in a variety of ways," the company said. Dorman's OE FIX Guide tells the stories behind these products in a way that helps techs better understand the problems Dorman's product experts uncovered, and understand the value of these new solutions.

07:02 EST Church & Dwight sees FY23 reported gross margin up 100-120 bps - "We expect full year reported gross margin to expand approximately 100 to 120 basis points versus 2022, as we expect pricing and productivity to more than offset inflation. Gross margin is expected to benefit from pricing, pack size changes, laundry concentration and the full year impact of the higher margin HERO business. This outlook includes incremental inflation headwinds of $125 million due to higher commodity and materials costs. However, we are seeing signs of inflation moderating in 2023. Supply chain fill levels continue to show improvement and we expect a return to pre-pandemic levels in the second half of 2023 as incremental capacity comes online."

06:58 EST Church & Dwight raises quarterly dividend 4% to 27.25c per share - The quarterly dividend will be payable March 1st, to stockholders of record at the close of business on February 15th.

06:51 EST Invitation Homes raises quarterly dividend 18% to 26c from 22c per share - The dividend will be paid on or before February 28 to stockholders of record of the company's common stock as of the close of business on February 14.

06:42 EST GrafTech provides 2023 outlook - The company said, "As we enter 2023, we anticipate continued soft demand for graphite electrodes due to ongoing economic uncertainty and geopolitical conflict. In addition, we expect the suspension of our operations in Monterrey, Mexico in late 2022 will have a significant impact on our sales volume for the first half of 2023. Although the facility has resumed production, the suspension resulted in uncertainty during a key commitment window for customer purchases covering the first six months of 2023. Reflecting these factors, we estimate our sales volume for the first six months of 2023 will be approximately half of the level reported in the same period of 2022, with the largest impact occurring in the first quarter. As we proceed into the second half of the year, we expect sales volume levels to recover, as we move past Monterrey suspension-driven uncertainty and anticipate that a gradual improvement in market conditions will strengthen demand for graphite electrodes. In 2023, we expect a significant year-over-year increase in our cost of goods sold per metric ton as fixed costs will be recognized over a smaller volume base and reflecting the full year impact of higher raw material costs that increased throughout 2022. In response, we are closely managing all of our operating costs and capital expenditures, as well as our working capital levels. Towards the end of the fourth quarter of 2022, we began proactively reducing production at our European graphite electrode manufacturing facilities, to align our production volume with our current demand outlook. Longer term, we remain confident that the steel industry's accelerating efforts to decarbonize will lead to increased adoption of the electric arc furnace method of steelmaking, driving long-term demand growth for graphite electrodes. We believe that the near-term actions we are taking, supported by an industry-leading position and our sustainable competitive advantages, will optimally position GrafTech to benefit from that long-term growth."

06:35 EST Regeneron announces new $3B share repurchase program - "We were pleased with our fourth-quarter and full-year 2022 financial performance, highlighted by revenue growth of 14% and 17%, respectively, when excluding contributions from REGEN-COV and Ronapreve, demonstrating the commercial strength and increasing diversity of our business," said Robert E. Landry, Executive Vice President, Finance and CFO of Regeneron. "In January 2023, our Board of Directors authorized a new $3.0 billion share repurchase program, enabling us to continue returning capital directly to shareholders. This year, we look forward to driving long-term shareholder value through continued investment in R&D, excellent commercial execution and strategic business development."

06:32 EST Regeneron sees FY23 CapEx $825M-$950M

06:30 EST Primo Water acquires additional spring water source in Arkansas - Primo Water announced that Primo Water has acquired an additional spring water source adjacent to its current Mountain Valley spring in Garland County, Arkansas.

05:59 EST Creative Media & Community Trust acquires three multifamily assets - CMCT announced that it is expanding its multifamily portfolio with the planned addition of 696 apartment units across three assets. CMCT intends to acquire an interest in the 75-unit Parkview Apartments located at 1902 Park Avenue in the Echo Park neighborhood of Los Angeles. The transaction is anticipated to close in mid-February. Parkview Apartments is located adjacent to 1910 W. Sunset Blvd., an eight-story office property that was acquired by CMCT in February 2022. In Oakland, CMCT is under contract to acquire Eleven Fifty Clay, at 1150 Clay Street, a 16-story apartment building offering 288 market-rate residences. The acquisition is anticipated to close in late March. On January 31, CMCT closed on the acquisition of Channel House, a 333-unit, eight-story apartment building at 40 Harrison Street.

05:02 EST Volvo CFO Tina Hultkvist to resign - Tina Hultkvist has decided to resign from her role as Volvo Group CFO and member of the executive board. She has 25 years of experience at Volvo Group and has served as the Volvo Group CFO since March 2022. Jan Ytterberg, previously Volvo Group CFO and member of the executive board, and currently in the role of Volvo Group senior advisor, will step in as acting CFO.